The immunoglobulin E-allergen interaction: A target for therapy of type I allergic diseases

International Archives of Allergy and Immunology

Volumn 116, Issue 3, 1998, Pages 167-176

  Valenta, Rudolf ^a,e   Almo, Steven ^c   Ball, Tanja ^a   Dolecek, Christiane ^a   Steinberger, Peter ^a   Laffer, Sylvia ^a   Eibensteiner, Petra ^a   Flicker, Sabine ^a   Vrtala, Susanne ^a   Spitzauer, Susanne ^a   Valent, Peter ^a   Denepoux, Stephan ^b   Kraft, Dietrich ^a   Banchereau, Jacques ^d   Lebecque, Serge ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MERCK RESEARCH LABORATORIES   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d Baylor Institute for Immunology   (United States)

^e UNIVERSITY OF VIENNA   (Austria)

Author keywords

Blocking antibody; Immunoglobulin E; Immunotherapy; Recombinant allergens; Type I allergy

Indexed keywords

ALLERGEN; EPITOPE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY;

EFFECTOR CELL; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW; SENSITIZATION;

ALLERGENS; ANIMALS; ANTIGEN-ANTIBODY REACTIONS; EPITOPES, B-LYMPHOCYTE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; VACCINATION;

EID: 7344242136     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023942     Document Type: Review

References (64)

1. Kay AB: Allergy and Allergic Diseases. Oxford; Blackwell Science. 1997.
2. Van-Neerven RJ, van de Pol MM, Wierenga EA, Aalberse RC, Jansen HM, Kapsenberg ML: Peptide specificity and HLA restriction do not dictate lymphokine production by allergen-specific T lymphocyte clones. Immunology 1994;82:351-356.
3. Ebner C, Schenk S, Najafian N, Siemann U, Steiner R, Fischer GW, Hoffmann K, Szepfalusi Z, Scheiner O, Kraft D: Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J Immunol 1995;154:1932-1940.
4. Saint-Remy JM, Lebrun PM, Lebecque SJ, Masson PL: Human immune response to allergens of house dust mite, Dermatophagoides pteronyssinus. Isotypic analysis of antibodies in atopic and non-atopic subjects. Allergy 1988;43:338-347.
5. Segal DM, Taurog JD, Metzger H: Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation. Proc Natl Acad Sci USA 1977;74:2993-2997.
6. Valenta R, Kraft D: Recombinant allergens for diagnosis and therapy of allergic diseases. Curr Opin Immunol 1995;7:751-756.
7. Valenta R, Steinberger P, Duchêne M, Kraft D: Immunological similarities among allergens: Prerequisite for a specific and component based therapy of allergy. Immunol Cell Biol 1996;74:187-194.
8. Valenta R, Vrtala S, Laffer S, Spitzauer S, Kraft D: Recombinant allergens. Allergy, in press.
9. Norman PS: Modern concepts of immunotherapy. Curr Opin Immunol 1993;5:968-973.
10. Sheffer AL: Allergen-specific immunotherapy: A role for T-cell anergy. Ann Allergy 1993;71: 327-329.
11. Yssel H, Fasler S, Lamb J, de Vries JE: Induction of non-responsiveness in human allergenspecific type 2 T helper cells. Curr Opin Immunol 1994;6:847-852.
12. Braden BC, Poljak RJ: Structural features of the reactions between antibodies and protein antigens. FASEB J 1995;9:9-16.
13. Geysen HM, Rodda SJ, Mason TJ, Tribbick G, Schoofs PG: Strategies for epitope analysis using peptide synthesis. J Immunol Methods 1987;102:259-274.
14. van t Hof W, Driedijk PC, van den Berg M, Beck-Sickinger AG, Jung G, Aalberse RC: Epitope mapping of the Dermatophagoides pteronyssinus house dust mite major allergen Der p 2 using overlapping synthetic peptides. Mol Immunol 1991;28:1225-1232.
15. Ball G, Shelton MJ, Walsh BJ, Hill DJ, Hosking CS, Howden ME: A major continuous allergenic epitope of bovine beta-lactoglobulin recognized by human IgE binding. Clin Exp Allergy 1994;24:758-764.
16. Ball T, Vrtala S, Sperr WR, Valent P, Susani M, Kraft D, Valenta R: Isolation of an immunodominant IgE hapten from an epitope expression cDNA library. J Biol Chem 1994;269: 28323-28328.
17. Collins SP, Ball G, Vonarx E, Hosking C, Shelton M, Hill D, Howden ME: Absence of continuous epitopes in the house dust mite major allergens Der p 1 from Dermatophagoides pteronyssinus and Der f 1 from Dermatophagoides farinae. Clin Exp Allergy 1996;26: 36-42.
18. Greene WK, Cyster JG, Chua KY, O'Brien RM. Thomas WR: IgE and IgG binding of peptides expressed from fragments of cDNA encoding the major house dust mite allergen Der p I. J Immunol 1991;147:3768-3773.
19. Ong EK, Knox RB, Singh MB: Mapping of the antigenic and allergenic epitopes of Lol p VB using gene fragmentation. Mol Immunol 1995; 32:295-302.
20. Schneider T, Lang AB, Carballido JM, Santamaria-Babi LF, Dudler T, Kagi MK, Blaser K, Suter M: Human monoclonal or polyclonal antibodies recognize predominantly discontinuous epitopes on the bee venom phospholipase A2. J Allergy Clin Immunol 1994;94:61-70.
21. Vrtala S, Hirtenlehner K, Vangelista L, Pastore A, Eichler HG, Sperr WR, Valent P, Ebner C, Kraft D, Valenta R: Conversion of the major birch pollen allergen. Bet v 1. into two nonanaphylactic T cell epitope-containing fragments. Candidates for a novel form of specific immunotherapy. J Clin Invest 1997;99:1673-1681.
22. 2+. EMBOJ 1994; 13:3481-3486.
23. Twardosz A, Hayek B, Sciberler S, Vangelista L, Elfman L, Grönlund H, Kraft D, Valenta R: Molecular characterization, expression in Escherichia coli, and epitope analysis of a two EF-hand calcium-binding birch pollen allergen. Bet v 4. Biochem Biophys Res Commun 1997;239:197-204.
24. Engel E, Richter K, Obermeyer G, Briza P, Kungl AJ, Simon B, Auer M, Ebner C, Rheinberger HJ, Breitenbach M, Ferreira F: Immunological and biological properties of Bet v 4. a novel birch pollen allergen with two EF-hand calcium-binding domains. J Biol Chem 1997;272:28630-28637.
25. Zeiler T, Taivainen A, Rytkönen M, Rautiainen J, Karjalainen H, Mäntyjärvi R, Tuomisto L, Virtanen T: Recombinant allergen fragments as candidate preparations for allergen immunotherapy. J Allergy Clin Immunol 1997; 100:721-727.
26. Gershoni JM, Stern B, Denisova G: Combinatorial libraries, epitope structure and the prediction of protein conformations. Immunol Today 1997;18:108-110.
27. Lebecque S, Dolecek C, Laffer S, Visco V, Denepoux S, Pin JJ, Guret C, Boltz-Nitulescu G, Weyer A, Valenta R: Immunologic characterization of monoclonal antibodies that modulate human IgE binding to the major birch pollen allergen Bet v 1. J Allergy Clin Immunol 1997;99:374-384.
28. Gajhede M, Osmark P, Poulsen FM, Ipsen H, Larsen JN, Joost van Neerven RJ, Schou C, Lowenstein H, Spangfort MD: X-ray and NMR structure of Bet v 1, the origin of birch pollen allergy. Nat Struct Biol 1996;3:1040-1045.
29. Fedorov AA, Ball T, Mahoney NM, Valenta R, Almo SC: The molecular basis for allergen cross-reactivity: Crystal structure and IgE-epitope mapping of birch pollen profilin. Structure 1997;5:33-45.
30. Fedorov AA, Ball T, Valenta R, Almo SC: X-ray crystal structures of birch pollen profilin and Phl p 2. Int Arch Allergy Immunol 1997; 113:109-113.
31. Bufe A, Betzel C, Schramm G, Petersen A, Becker WM, Schlaak M, Perbandt M, Dauter Z, Weber W: Crystallization and preliminary diffraction data of a major pollen allergen. Crystal growth separates a low molecular weight form with elevated biological activity. J Biol Chem 1996;271:27193-27196.
32. Müller GA, Smith AM, Williams DC Jr, Hakkaart GA, Aalberse RC, Chapman MD, Rule GS, Benjamin DC: Expression and secondary structure determination by NMR methods of the major house dust mite allergen Der p 2. J Biol Chem 1997;272:26893-26898.
33. Thorn KS, Christensen HEM, Shigeta R Jr, Huddler D, Shalaby L, Lindberg U, Chua NH, Schutt CE: The crystal structure of a major allergen from plants. Structure 1997;5:19-32.
34. Valenta R, Duchêne M, Pettenburger K, Sillaber C, Valent P, Bettelheim P, Breitenbach M, Rumpold H, Kraft D, Scheiner O: Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals. Science 1991;253:557-560.
35. Valenta R, Duchêne M, Ebner C, Valent P, Sillaber C, Deviller P, Ferreira F, ,Tejkl M, Edelmann H, Kraft D, Scheiner O: Profilins constitute a novel family of functional plant pan-allergens. J Exp Med 1992;175:377-385.
36. Schutt CE, Myslik JC, Rozycki MD, Goonesekere NCW, Lindberg U: The structure of crystalline profilin-β-actin. Nature 1993;365: 810-816.
37. Domke T, Federau T, Schlüter K, Giehl K, Valenta R, Schomburg D, Jockusch BM: Birch pollen profilin: Structural organization and interaction with poly-(L-proline) peptides as revealed by NMR. FEBS Lett 1997;411:291-295.
38. Steinberger P, Kraft D, Valenta R: Construction of a combinatorial IgE library from an allergic patient: Isolation and characterization of human IgE Fabs with specificity for the major timothy grass pollen allergen. PhI p 5. J Biol Chem 1996;271:10967-10972.
39. deWeck AL, Jeunet F, Schulz KH, Louis P, Girard JP, Grilliat JP, Moneret-Vautrin D, Storck H, Wüthrich B, Spengler H, Juhlin L, Scheiffarth F, Warnatz H, Wortmann F, Virgaay SRN: Clinical trial of Ro 6-0787, a monovalent specific hapten inhibitor of penicillin allergy. Z Immunitätsforsch 1975;150:138-160.
40. Richter W, Hedin H, Kraft D, Messmer K: Anaphylactoid reactions after dextran II. Experimental studies in animals on the principle of hapten inhibition. Beitr Infusionsther Klin Ernähr 1981;8:54-65.
41. Niederberger V, Pauli G, Grönlund H, Fröschl R, Rumpold H, Kraft D, Valenta R, Spitzauer S: Recombinant birch pollen allergens (rBet v 1. rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel and oak pollen. A quantitative IgE inhibition study using sera from different populations. J Allergy Clin Immunol 1998:in press.
42. Niederberger V, Laffer S, Fröschl R, Kraft D, Rumpold H, Kapiotis S, Valenta R, Spitzauer S: IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2. Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE. J Allergy Clin Immunol 1998; 101:258-264.
43. Tanabe S, Tesaki S, Yanagihara Y, Mita H, Takahashi K, Arai S, Watanabe M: Inhibition of basophil histamine release by a haptenic peptide mixture prepared by chymotryptic hydrolysis of wheat fluor. Biochem Biophys Res Commun 1996;223:492-495.
44. Daeron M, Malbec O, Latour S, Arock M, Fridman WH: Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest 1995;95:577-585.
45. Cooke RA, Bernhard JH, Hebald S, Stull A: Serological evidence of immunity with co-existing sensitization in hay fever type of human allergy. J Exp Med 1935;62:733-750.
46. Loveless MH: Immunological studies of pollinosis. I. The presence of two antibodies related to the same pollen-antigen in serum of treated hay fever patients. J Immunol 1940;38:25-50.
47. Visco V, Dolecek C, Denepoux S, Mao JL, Guret C, Rousset F, Guinnepain MT, Kraft D, Valenta R, Weyer A, Banchereau J, Lebecque S: Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1. J Immunol 1996;157:956-962.
48. Valenta R, Flicker S, Eibensteiner PB, Laffer S, Steinberger P, Kraft D: Recombinant allergen fragments: Tools for diagnosis, prevention and therapy of type I allergy. Biol Chem 1997; 378:745-748.
49. Gram H, Marconi LA, Barbas CF III, Collet TA, Lerner RA, Kang AS: In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library. Proc Natl Acad Sci USA 1992;89:3576-3580.
50. Lichtenstein LM, Holtzman NA, Burnett LS: A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody. J Immunol 1968;101:317-324.
51. Aalberse RC, Gaag R, Leeuwen J: Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 1983;130:722-726.
52. Birkner T, Rumpold H, Jarolim E, Ebner H, Breitenbach M, Skvaril F, Scheiner O, Kraft D: Evaluation of immunotherapy-induced changes in specific IgE. IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting. Allergy 1990;45:418-426.
53. Menz G, Dolecek C, Schönheit-Kenn U, Ferreira F, Moser M, Schneider T, Suter M, BoltzNitulescu G, Ebner C, Kraft D, Valenta R: Serological and skin-test diagnosis of birch pollen allergy with recombinant Bet v 1, the major birch pollen allergen. Clin Exp Allergy 1996;26:50-60.
54. Pauli G, Oster JP, Deviller P, Heiss S, Bessot J, Susani M, Ferreira F, Kraft D, Valenta R: Skin testing with recombinant allergens rBet v 1 and rBet v 2. Diagnostic value for birch pollen and associated allergies. J Allergy Clin Immunol 1996;97:1100-1109.
55. Vrtala S, Susani M, Sperr WR, Valent P, Laffer S, Dolecek C, Kraft D, Valenta R: Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p 2, Phl p 5). J Allergy Clin Immunol 1996;97:781-787.
56. Tame A, Sakiyama Y, Kobayashi I, Terai I, Kobayashi K: Differences in titres of IgE. IgG4 and other IgG subclass anti-Der p 2 antibodies in allergic and non-allergic patients measured with recombinant allergen. Clin Exp Allergy 1996;26:43-49.
57. Kobayashi I, Sakiyama Y, Tame A, Kobayashi K, Matsumoto S: IgE and IgG4 antibodies from patients with mite allergy recognize different epitopes of Dermatophagoides pteronyssinus group II antigen (Der p 2). J Allergy Clin Immunol 1996;97:638-645.
58. Valenta R, Ball T: Antibody recognition of recombinant allergens and allergen fragments: Evidence for a predominantly direct class switch to IgE in allergic patients, in Vercelli D (ed): IgE Regulation: Molecular Mechanisms. Chichester, Wiley, 1997, pp 225-236.
59. Vrtala S, Ball T, Spitzauer S, Pandjaitan B, Suphioglu C, Knox B, Sperr WR, Valent P, Kraft D, Valenta R: Immunization with purified natural and recombinant allergens induces mouse IgGl antibodies that recognize similar epitopes as human IgE, inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation. J Immunol, in press.
60. Smith AM, Chapman MD: Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: Contribution of disulfide bonds. Mol Immunol 1996;33:399-406.
61. Noguchi E, Shibasaki M, Nishiyama C, Okumura Y, Takita H: IgE responsiveness to Dermatophagoides farinae in young asthmatic children: IgE binding study using recombinant allergens of Der f 1, Der f 2 and mutant proteins of Der f 2. Int Arch Allergy Immunol 1996;110:380-387.
62. Takai T, Yokota T, Yasue M, Nishiyama C, Yuuki T, Mori A, Okudaira H, Okumura Y: Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy. Nat Biotechnol 1997;15:754-758.
63. Ferreira F, Hirtenlehner K, Jilek A, Godnick-Cvar J, Breiteneder H, Grimm R, Hoffmann-Sommergruber K, Scheiner O, Kraft D, Breitenbach M, Rheinberger HJ, Ebner C: Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: Potential use of hypoallergenic isoforms for immunotherapy. J Exp Med 1996;183:599-609.
64. Kolbe L, Heusser CH, Kolsch E: Isotype-associated recognition of allergen epitopes and its modulation by antigen dose. Immunology 1995;84:285-289.